Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (15,720,781)	$ (7,062,210)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	14,699,171	4,612,086
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets	(811,946)	(134,706)
Accounts payable and accrued liabilities	1,130,891	1,133,740
Due to affiliates	1,538,572	165,096
Net cash provided by (used in) operating activities	835,907	(1,285,994)
Cash flows from investing activities:
Purchase of real estate	(170,123,441)	(103,494,500)
Additions to real estate	(1,882,767)	(34,516)
Investment in equity method investment	(763,834)	(1,031,903)
Deposits on acquisition of real estate facilities		(1,000,000)
Investment in company-owned life insurance		(876,313)
Net cash used in investing activities	(172,770,042)	(106,437,232)
Cash flows from financing activities:
Proceeds from issuance of non-revolving mortgage debt	110,105,000	53,000,000
Proceeds from issuance of KeyBank Bridge Loans	55,119,820	39,896,363
Principal payments of KeyBank Bridge Loans	(12,304,891)	(39,896,363)
Debt issuance costs	(2,242,169)	(1,491,357)
Issuance of preferred equity in our Operating Partnership	10,064,950	5,650,000
Redemption of preferred equity in our Operating Partnership		(6,722,055)
Gross proceeds from issuance of common stock	18,131,683	75,517,069
Offering costs	(1,919,882)	(6,346,855)
Deferred offering costs		(856,306)
Distributions paid to common stockholders	(4,105,267)	(616,387)
Distributions paid to preferred unitholders in our Operating Partnership		(239,885)
Distributions paid to Operating Partnership unitholders	(14,496)
Issuance of noncontrolling interest in our Operating Partnership		199,000
Net cash provided by financing activities	172,834,748	118,093,224
Net change in cash, cash equivalents, and restricted cash	900,613	10,369,998
Cash, cash equivalents, and restricted cash, beginning of year	10,371,998	2,000
Cash, cash equivalents, and restricted cash, end of year	11,272,611	10,371,998
Supplemental disclosures and non-cash transactions:
Cash paid for interest	6,440,337	928,474
Interest capitalized	47,333
Debt issuance costs included in due to affiliates		33,882
Deposits applied to purchase of real estate	1,000,000
Deposits applied to debt issuance costs	123,100
Acquisition costs included in due to affiliates	1,980,000
Additions to real estate facilities included in accounts payable and accrued liabilities	1,144,210
Other assets included in accounts payable and accrued liabilities	67,478
Offering costs included in accounts payable and accrued liabilities or due to affiliates	821,523	135,002
Deferred offering costs included in accounts payable and accrued liabilities		107,653
Non-cash preferred equity issuance in our Operating Partnership	100,649	1,072,055
Distributions payable	908,046	463,848
Redemptions of common stock included in accounts payable and accrued liabilities	15,300
Issuance of shares pursuant to distribution reinvestment plan	$ 2,371,110	$ 303,844